Literature DB >> 23586854

A rightward shift of the distribution of fasting and post-load glucose in northern Sweden between 1990 and 2009 and its predictors. Data from the Northern Sweden MONICA study.

M Lilja1, M Eliasson, M Eriksson, S Söderberg.   

Abstract

AIMS: Most Swedish studies show stable diabetes prevalence despite increasing obesity, but glucose levels may shift upwards below the diagnostic threshold for diabetes. Our aim was to explore trends in glucose distribution in northern Sweden; whether these trends were uniformly distributed throughout the spectrum of glucose concentrations; and to relate trends to traditional risk factors and the obesity-related adipokine leptin.
METHODS: The project consisted of four cross-sectional surveys between 1990 and 2009, with 7069 participants aged 25-64 years. The overall participation rate was 74.4%. Trend analyses of glucose concentrations along the entire distribution and linear regression in relation to survey years and risk markers were used.
RESULTS: Fasting and post-load glucose increased in women (both P < 0.001) and post-load glucose in men (P = 0.004). The increase was seen in most deciles of glucose concentrations. The prevalence of impaired glucose tolerance doubled in women to 14.5% and tripled in men to 10.1% (both P = 0.004). The prevalence of impaired fasting glucose rose in women from 4.5 to 7.7% (P < 0.001). The prevalence of diabetes was unchanged-6.4% in 2009. In men, leptin, together with traditional risk factors, explained 7.8 and 10.8% of the variance in fasting (P = 0.008) and post-load (P < 0.001) glucose, respectively.
CONCLUSIONS: Increasing fasting and post-load glucose concentrations were seen in most deciles of the glucose distribution, indicating a shift in the entire population. Leptin was significantly associated with fasting and post-load glucose in men.
© 2013 The Authors. Diabetic Medicine © 2013 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23586854     DOI: 10.1111/dme.12208

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

1.  Chronic overeating impairs hepatic glucose uptake and disposition.

Authors:  Katie C Coate; Guillaume Kraft; Masakazu Shiota; Marta S Smith; Ben Farmer; Doss W Neal; Phil Williams; Alan D Cherrington; Mary Courtney Moore
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-03-17       Impact factor: 4.310

2.  Prevalence and incidence of diabetes in Stockholm County 1990-2010.

Authors:  Tomas Andersson; Anders Ahlbom; Cecilia Magnusson; Sofia Carlsson
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

3.  The Swedish CArdioPulmonary BioImage Study: objectives and design.

Authors:  G Bergström; G Berglund; A Blomberg; J Brandberg; G Engström; J Engvall; M Eriksson; U de Faire; A Flinck; M G Hansson; B Hedblad; O Hjelmgren; C Janson; T Jernberg; Å Johnsson; L Johansson; L Lind; C-G Löfdahl; O Melander; C J Östgren; A Persson; M Persson; A Sandström; C Schmidt; S Söderberg; J Sundström; K Toren; A Waldenström; H Wedel; J Vikgren; B Fagerberg; A Rosengren
Journal:  J Intern Med       Date:  2015-06-19       Impact factor: 8.989

4.  Health care use, drug treatment and comorbidity in patients with schizophrenia or non-affective psychosis in Sweden: a cross-sectional study.

Authors:  Erica M Brostedt; Mussie Msghina; Marie Persson; Björn Wettermark
Journal:  BMC Psychiatry       Date:  2017-12-29       Impact factor: 3.630

5.  Increase in glycemic set point, alongside a decrease in waist circumference, in the non-diabetic population during the Japanese National Intervention Program for metabolic syndrome: A single-center, large-scale, matched-pair analysis.

Authors:  Takuya Sugiyama; Yuya Yamada; Yoshito Ito; Ryohei Mineo; Ryuya Iwamoto; Sachiko Tamba; Takashi Fujimoto; Koji Yamamoto; Yuji Matsuzawa
Journal:  PLoS One       Date:  2022-08-10       Impact factor: 3.752

6.  Cardiovascular risk factors differ between rural and urban Sweden: the 2009 Northern Sweden MONICA cohort.

Authors:  Martin Lindroth; Robert Lundqvist; Mikael Lilja; Mats Eliasson
Journal:  BMC Public Health       Date:  2014-08-09       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.